Will FDA approve any mRNA vaccine against pancreatic adenocarcinoma before 2028?
Basic
7
Ṁ783
2027
19%
chance

Resolves YES if the FDA grants full approval for the commercial sale of any mRNA vaccine against pancreatic adenocarcinoma in the United States before January 1, 2028. This does not include emergency use authorization or other forms of limited authorization. Resolves NO otherwise.

Get
Ṁ1,000
and
S3.00
Sort by:

AFAIK the only real candidate here is the KRAS vaccine (mRNA-5671). I think it might work against some of the cancers but pancreatic is pretty unlikely - pancreatic quite low mutational load, and is not normally responsive to immunotherapy. If it works I would expect it to be restricted to MSI-high pancreatic.

© Manifold Markets, Inc.Terms + Mana-only TermsPrivacyRules